Compare Immunovant Inc. Common Stock (IMVT) vs Sempra Energy (SRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Sempra Energy — how do they compare? Immunovant Inc. Common Stock trades at $30.38 (market cap $6.25B), while Sempra Energy trades at $80.62 (market cap $52.36B). The key difference: Sempra Energy is far larger — about 8.4× Immunovant Inc. Common Stock's market cap, and Sempra Energy pays a 3.28% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Sempra Energy for 8 Days on average.
| IMVT | SRE | |
|---|---|---|
Market Cap | $6.25B | $52.36B |
Volume | 1,755,411 | 3,338,383 |
Sector | Health | Utilities |
52-Week High | $44.96 | $99.75 |
52-Week Low | $17.03 | $76.90 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $5.35B | $89.00B |
Dividend Yield | — | 3.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Sempra Energy
Sempra is an energy infrastructure company with regulated utility and energy network businesses. Its operations include electric and gas utilities as well as energy infrastructure in North America.
Read more on SRE →
